PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/

Institutional investor · Portfolio as of Q2 2024

SEC EDGAR SourceSEC Filings

Top Holdings2,976 positions

Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

136.7M$61.1B7.3%$234.22+88.71%
7 qtrssince 2022-Q4
Decreased
0

NVIDIA CORPORATION

444.6M$54.9B6.6%$112.19+10.08%
7 qtrssince 2022-Q4
Increased
100

APPLE INC

228.5M$48.1B5.8%$136.48+53.13%
7 qtrssince 2022-Q4
Increased
68

AMAZON COM INC

181.6M$35.1B4.2%$89.52+115.86%
7 qtrssince 2022-Q4
Decreased
0

META PLATFORMS INC

41.7M$21B2.5%$162.86+208.08%
7 qtrssince 2022-Q4
Decreased
0

ELI LILLY & CO

20.7M$18.7B2.2%$363.49+146.08%
7 qtrssince 2022-Q4
Increased
55

ALPHABET INC

98.1M$17.9B2.1%$89.37+102.52%
7 qtrssince 2022-Q4
Decreased
0

ALPHABET INC

84.6M$15.5B1.9%$88.07+106.95%
7 qtrssince 2022-Q4
Decreased
0

UNITEDHEALTH GROUP INC

26M$13.3B1.6%$501.81-1.68%
7 qtrssince 2022-Q4
Decreased
0

VISA INC

44.3M$11.6B1.4%$202.70+27.81%
7 qtrssince 2022-Q4
Decreased
0

MASTERCARD INCORPORATED

19.3M$8.5B1.0%$341.16+28.02%
7 qtrssince 2022-Q4
Decreased
0

NETFLIX INC.

12.3M$8.3B1.0%$32.65+106.68%
7 qtrssince 2022-Q4
Increased
48

INTUITIVE SURGICAL INC

15.8M$7B0.8%$266.51+66.92%
7 qtrssince 2022-Q4
Decreased
0

ELEVANCE HEALTH INC FORMERLY

11.6M$6.3B0.8%$488.16+8.12%
7 qtrssince 2022-Q4
Decreased
0

SCHWAB CHARLES CORP

85.2M$6.3B0.8%$70.10+2.74%
7 qtrssince 2022-Q4
Increased
53

JPMORGAN CHASE & CO

31M$6.3B0.7%$124.76+56.23%
7 qtrssince 2022-Q4
Decreased
0

SERVICENOW INC

7.7M$6.1B0.7%$77.65+102.61%
7 qtrssince 2022-Q4
Decreased
0

BROADCOM INC

3.6M$5.7B0.7%$89.64+76.44%
7 qtrssince 2022-Q4
Increased
60

EXXON MOBIL CORP

49.4M$5.7B0.7%$99.98+8.56%
7 qtrssince 2022-Q4
Increased
49

INTUIT

8.6M$5.6B0.7%$380.88+70.58%
7 qtrssince 2022-Q4
Decreased
0
Showing 20 of 2,976 results.2,956 more with Pro.PROUpgrade to see all →
$835.7B
AUM
2,976
Positions
Q2 2024
Filing
Rating · 4.0
Quarterly Portfolio Change
+7%Q1'23$668B+7%Q2'23$717.6B-5%Q3'23$682.4B+9%Q4'23$744.2B+10%Q1'24$815.9B+2%Q2'24$835.7B
Activity profile
$ moved · Q2'24
New1%Increased52%Decreased47%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q4%1-4Q6%1-2Y88%2Y+2%

PRICE T ROWE ASSOCIATES INC /MD/ manages $835.7B across 2976 positions as of Q2 2024. Top holdings: MSFT (7.3%), NVDA (6.6%), AAPL (5.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q2 2024 Summary

Active quarter - 140 new positions, 119 exits, 1847 increased. Top move: NVDA (INCREASED, conviction 100). Portfolio: $835.7B across 2976 positions.

Top holdings by portfolio weight

Total AUM$836B
MSFT7.31%
NVDA6.57%
AAPL5.76%
AMZN4.20%
META2.52%
LLY2.24%
GOOGL2.14%
GOOG1.86%
UNH1.59%
V1.39%
Other1.02%

Portfolio allocation by GICS sector

Sectors11
Technology33.29%
Healthcare14.71%
Financial Services10.33%
Consumer Cyclical10.10%
Communication Services9.22%
Industrials7.20%
Energy4.17%
Consumer Defensive4.03%
Real Estate2.28%
Basic Materials1.90%
Other2.78%

Behavioral investing profile

7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record52
Conviction44
Concentration0
Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
AIRAAR CORP
Q3 2024 Q1 2026+22,821 shares+$3.3M
7Q
ADMAADMA BIOLOGICS INC
Q3 2024 Q1 2026+139,957 shares-$3.2M
7Q
ADTADT INC DEL
Q3 2024 Q1 2026+263,094 shares+$1.6M

Upgrade to Pro to see all accumulation streaks

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used